Caveolin‐1: an ambiguous partner in cell signalling and cancer

Abstract

Introduction The caveolins Caveolin‐1 in cell physiology Caveolin‐1 in cancer Concluding remarks Caveolae are small plasma membrane invaginations that have been implicated in a variety of functions including transcytosis, potocytosis and cholesterol transport and signal transduction. The major protein component of this compartment is a family of proteins called caveolins. Experimental data obtained in knockout mice have provided unequivocal evidence for a requirement of caveolins to generate morphologically detectable caveolae structures. However, expression of caveolins is not sufficient per seto assure the presence of these structures. With respect to other roles attributed to caveolins in the regulation of cellular function, insights are even less clear. Here we will consider, more specifically, the data concerning the ambiguous roles ascribed to caveolin‐1 in signal transduction and cancer. In particular, evidence indicating that caveolin‐1 function is cell context dependent will be discussed.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 228

1. 1.

   Yamada E. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol. 1955;1:445-58.

   Not in our library10.1083/jcb.1.5.445

2. 2.

   Palade GE. Fine structure of blood capillaries. J Appl Phys. 1953;24:1424.

   Not in our library

3. 3.

   Anderson RG. The caveolae membrane system. Annu Rev Biochem. 1998;67:199-225.

   Not in our library10.1146/annurev.biochem.67.1.199

4. 4.

   Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol. 1998;14:111-36.

   Not in our library10.1146/annurev.cellbio.14.1.111

5. 5.

   Brown DA, Rose JK. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell. 1992;68:533-44.

   Not in our library10.1016/0092-8674(92)90189-j

6. 6.

   Pike LJ. Rafts defined: a report on the Keystone Symposium on Lipid Rafts and Cell Function. J Lipid Res. 2006;47:1597-8.

   Not in our library10.1194/jlr.e600002-jlr200

7. 7.

   Brown DA. Seeing is believing: visualization of rafts in model membranes. Proc Natl Acad Sci USA. 2001;98:10517-8.

   Not in our library10.1073/pnas.191386898

8. 8.

   Bacia K, Schwille P, Kurzchalia T. Sterol structure determines the separation of phases and the curvature of the liquid-ordered phase in model membranes. Proc Natl Acad Sci USA. 2005;102:3272-7.

   Not in our library10.1073/pnas.0408215102

9. 9.

   Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem. 2001;276:38121-38.

   Not in our library10.1074/jbc.m105408200

10. 10.

    Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 2001;293:2449-52.

    Not in our library10.1126/science.1062688

11. 11.

    Minetti C, Bado M, Broda P, Sotgia F, Bruno C, Galbiati F, Volonte D, Lucania G, Pavan A, Bonilla E, Lisanti MP, Cordone G. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency. Am J Pathol. 2002;160:265-70.

    Not in our library10.1016/s0002-9440(10)64370-2

12. 12.

    Park DS, Woodman SE, Schubert W, Cohen AW, Frank PG, Chandra M, Shirani J, Razani B, Tang B, Jelicks LA, Factor SM, Weiss LM, Tanowitz HB, Lisanti MP. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol. 2002;160:2207-17.

    Not in our library10.1016/s0002-9440(10)61168-6

13. 13.

    Pelkmans L, Zerial M. Kinase-regulated quantal assemblies and kiss-and-run recycling of caveolae. Nature. 2005;436:128-33.

    Not in our library10.1038/nature03866

14. 14.

    Parton RG, Hanzal-Bayer M, Hancock JF. Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J Cell Sci. 2006;119:787-96.

    Not in our library10.1242/jcs.02853

15. 15.

    Nabi IR, Le PU. Caveolae/raft-dependent endocytosis. J Cell Biol. 2003;161:673-7.

    Not in our library10.1083/jcb.200302028

16. 16.

    Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol. 2007;8:185-94.

    Not in our library10.1038/nrm2122

17. 17.

    Williams TM, Lisanti MP. The caveolin proteins. Genome Biol. 2004;5:214.

    Not in our library10.1186/gb-2004-5-3-214

18. 18.

    Okamoto T, Schlegel A, Scherer PE, Lisanti MP. Caveolins, a family of scaffolding proteins for organizing ‘preassembled signaling complexes' at the plasma mem-brane. J Biol Chem. 1998;273:5419-22.

    Not in our library10.1074/jbc.273.10.5419

19. 19.

    Razani B, Schlegel A, Lisanti MP. Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. J Cell Sci. 2000;113:2103-9.

    Not in our library10.1242/jcs.113.12.2103

20. 20.

    Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem. 1996;271:2255-61.

    Not in our library10.1074/jbc.271.4.2255

21. 21.

    Silva WI, Maldonado HM, Velazquez G, Rubio-Davila M, Miranda JD, Aquino E, Mayol N, Cruz-Torres A, Jardon J, Salgado-Villanueva IK. Caveolin isoform expression during differentiation of C6 glioma cells. Int J Dev Neurosci. 2005;23:599-612.

    Not in our library10.1016/j.ijdevneu.2005.07.007

22. 22.

    Razani B, Wang XB, Engelman JA, Battista M, Lagaud G, Zhang XL, Kneitz B, Hou H, Christ GJ, Edelmann W, Lisanti MP. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol Cell Biol. 2002;22:2329-44.

    Not in our library10.1128/mcb.22.7.2329-2344.2002

23. 23.

    Razani B, Woodman SE, Lisanti MP. Caveolae: from cell biology to animal physiology. Pharmacol Rev. 2002;54:431-67.

    Not in our library10.1124/pr.54.3.431

24. 24.

    Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou H, Kneitz B, Edelmann W, Lisanti MP. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J Biol Chem. 2001;276:21425-33.

    Not in our library10.1074/jbc.m100828200

25. 25.

    Quest AF, Leyton L, Parraga M. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem Cell Biol. 2004;82:129-44.

    Not in our library10.1139/o03-071

26. 26.

    Liu L, Pilch PF. A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. J Biol Chem. 2008;283:4314-22.

    Not in our library10.1074/jbc.m707890200

27. 27.

    Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, Nixon SJ, Walser P, Abankwa D, Oorschot VM, Martin S, Hancock JF, Parton RG. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell. 2008;132:113-24.

    Not in our library10.1016/j.cell.2007.11.042

28. 28.

    Kogo H, Aiba T, Fujimoto T. Cell type-specific occurrence of caveolin-1alpha and -1beta in the lung caused by expression of distinct mRNAs. J Biol Chem. 2004;279:25574-81.

    Not in our library10.1074/jbc.m310807200

29. 29.

    Kogo H, Fujimoto T. Caveolin-1 isoforms are encoded by distinct mRNAs. Identification Of mouse caveolin-1 mRNA variants caused by alternative transcription initiation and splicing. FEBS Lett. 2000;465:119-23.

    Not in our library10.1016/s0014-5793(99)01730-5

30. 30.

    Scherer PE, Tang Z, Chun M, Sargiacomo M, Lodish HF, Lisanti MP. Caveolin iso-forms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J Biol Chem. 1995;270:16395-401.

    Not in our library10.1074/jbc.270.27.16395

31. 31.

    Fujimoto T, Kogo H, Nomura R, Une T. Isoforms of caveolin-1 and caveolar structure. J Cell Sci. 2000;113:3509-17.

    Not in our library10.1242/jcs.113.19.3509

32. 32.

    Fang PK, Solomon KR, Zhuang L, Qi M, McKee M, Freeman MR, Yelick PC. Caveolin-1alpha and -1beta perform nonredundant roles in early vertebrate development. Am J Pathol. 2006;169:2209-22.

    Not in our library10.2353/ajpath.2006.060562

33. 33.

    Glenney JR. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J Biol Chem. 1989;264:20163-6.

    Not in our library

34. 34.

    Glenney JR, Soppet D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc Natl Acad Sci USA. 1992;89:10517-21.

    Not in our library10.1073/pnas.89.21.10517

35. 35.

    Glenney JR, Zokas L. Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J Cell Biol. 1989;108:2401-8.

    Not in our library10.1083/jcb.108.6.2401

36. 36.

    Mastick CC, Saltiel AR. Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells. J Biol Chem. 1997;272:20706-14.

    Not in our library10.1074/jbc.272.33.20706

37. 37.

    Kimura A, Mora S, Shigematsu S, Pessin JE, Saltiel AR. The insulin receptor catalyzes the tyrosine phosphorylation of caveolin-1. J Biol Chem. 2002;277:30153-8.

    Not in our library10.1074/jbc.m203375200

38. 38.

    Mastick CC, Brady MJ, Saltiel AR. Insulin stimulates the tyrosine phosphorylation of caveolin. J Cell Biol. 1995;129:1523-31.

    Not in our library10.1083/jcb.129.6.1523

39. 39.

    Lee H, Volonte D, Galbiati F, Iyengar P, Lublin DM, Bregman DB, Wilson MT, Campos-Gonzalez R, Bouzahzah B, Pestell RG, Scherer PE, Lisanti MP. Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol. 2000;14:1750-75.

    Not in our library10.1210/mend.14.11.0553

40. 40.

    Orlichenko L, Huang B, Krueger E, McNiven MA. Epithelial growth factor-induced phosphorylation of caveolin 1 at tyrosine 14 stimulates caveolae formation in epithelial cells. J Biol Chem. 2006;281:4570-9.

    Not in our library10.1074/jbc.m512088200

Cited by papers we hold 3

• Endocytosis: a pivotal pathway for regulating metastasis · 2020
  No notice
• Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo · 2016
  No notice
• Tumor Suppression and Promotion by Autophagy · 2014
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.